S Swanton

5.0k total citations · 2 hit papers
11 papers, 3.7k citations indexed

About

S Swanton is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, S Swanton has authored 11 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in S Swanton's work include Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). S Swanton is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). S Swanton collaborates with scholars based in United Kingdom, Australia and Austria. S Swanton's co-authors include Anthony J. Bench, E. Joanna Baxter, Nasios Fourouclas, Clare East, Peter J. Campbell, Linda M. Scott, George S. Vassiliou, Elaine Boyd, Natasha Joan Curtin and Anthony R. Green and has published in prestigious journals such as The Lancet, Oncogene and British Journal of Haematology.

In The Last Decade

S Swanton

11 papers receiving 3.6k citations

Hit Papers

Acquired mutation of the tyrosine kinase JAK2 in human my... 2005 2026 2012 2019 2005 2005 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Swanton United Kingdom 8 3.1k 2.2k 1.9k 1.3k 594 11 3.7k
Nasios Fourouclas United Kingdom 7 3.1k 1.0× 2.1k 0.9× 1.9k 1.0× 1.3k 1.0× 601 1.0× 8 3.6k
Catherine Lacout France 22 3.3k 1.1× 2.6k 1.2× 2.2k 1.2× 1.3k 1.0× 740 1.2× 47 4.3k
Elaine Boyd United Kingdom 8 3.7k 1.2× 2.4k 1.1× 2.3k 1.2× 1.6k 1.2× 618 1.0× 9 4.2k
Clare East United Kingdom 7 4.2k 1.4× 2.7k 1.2× 2.6k 1.4× 1.8k 1.4× 610 1.0× 14 4.7k
Natasha Joan Curtin United Kingdom 5 3.0k 1.0× 2.0k 0.9× 1.8k 1.0× 1.3k 1.0× 578 1.0× 6 3.5k
François Delhommeau France 26 3.7k 1.2× 3.0k 1.4× 2.7k 1.4× 1.4k 1.1× 657 1.1× 81 5.2k
Daniela Pietra Italy 35 3.5k 1.1× 2.9k 1.3× 2.4k 1.3× 1.4k 1.0× 201 0.3× 82 4.3k
Francesca Palandri Italy 30 2.2k 0.7× 2.4k 1.1× 653 0.3× 1.2k 1.0× 293 0.5× 180 3.2k
Éric Lippert France 23 1.4k 0.5× 1.3k 0.6× 968 0.5× 603 0.5× 278 0.5× 102 2.2k
Rebecca F. McClure United States 31 2.9k 0.9× 2.4k 1.1× 2.0k 1.0× 1.4k 1.1× 515 0.9× 64 4.5k

Countries citing papers authored by S Swanton

Since Specialization
Citations

This map shows the geographic impact of S Swanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Swanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Swanton more than expected).

Fields of papers citing papers by S Swanton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Swanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Swanton. The network helps show where S Swanton may publish in the future.

Co-authorship network of co-authors of S Swanton

This figure shows the co-authorship network connecting the top 25 collaborators of S Swanton. A scholar is included among the top collaborators of S Swanton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Swanton. S Swanton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fourouclas, Nasios, et al.. (2006). Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia.. PubMed. 91(7). 952–5. 27 indexed citations
2.
Vassiliou, George S., Irene Roberts, S Swanton, et al.. (2006). An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation.. PubMed. 91(8). 1100–4. 3 indexed citations
3.
Baxter, E. Joanna, Linda M. Scott, Peter J. Campbell, et al.. (2005). Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. The Lancet. 365(9464). 1054–1061. 2554 indexed citations breakdown →
4.
Baxter, E. Joanna, Linda M. Scott, Peter J. Campbell, et al.. (2005). Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. The Lancet. 365(9464). 1054–1061. 846 indexed citations breakdown →
5.
Reid, Alistair, S Swanton, Colin Grace, et al.. (2003). Double Philadelphia masquerading as chromosome 20q deletion – a new recurrent abnormality in chronic myeloid leukaemia blast crisis. British Journal of Haematology. 123(3). 442–448. 4 indexed citations
6.
Bench, Anthony J., Elisabeth P. Nacheva, Lisa French, et al.. (2000). Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. Oncogene. 19(34). 3902–3913. 112 indexed citations
7.
Swanton, S, et al.. (1999). Abnormalities of the long arm of chromosome 20 in myeloid malignancies. UCL Discovery (University College London). 2 indexed citations
8.
Coignet, Lionel, Carmen Sílvia Passos Lima, Toon Min, et al.. (1999). Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia. Genes Chromosomes and Cancer. 25(3). 222–229. 25 indexed citations
9.
Balogh, Erzsébet, et al.. (1998). Fluorescence In Situ Hybridization Reveals Trisomy 2q by Insertion into 9p in Hepatoblastoma. Cancer Genetics and Cytogenetics. 102(2). 148–150. 13 indexed citations
10.
Johansson, Bertil, Anthony V. Moorman, OA Haas, et al.. (1998). Hematologic malignancies with t(4;11)(q21;q23) – a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. Leukemia. 12(5). 779–787. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026